Uterotonic Prophylaxis Trial
NCT02408965
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
284
Enrollment
OTHER
Sponsor class
Conditions
Hemorrhage
Interventions
DRUG:
Methergine
OTHER:
placebo
Sponsor
University of California, San Francisco